Covid: Mensually offered alternative to Oxford-AstraZeneca Jab

By Nick TransgleHealth Correspondent Published 1 day AgocommentsCommentsSharecloshare Pageecopy Linkabout SharingreledRelated Topics Media CaptionStrazeneca Covid Vaccine Risks and Benefits" more Finante Balance "in younger people, says Mhra Coo June Raine < P> Minors of 30 years in the United Kingdom will be offered an alternative COVID vaccine to the AstraZeneca card due to the evidence that unites it to rare blood clots.

The recommendation comes after a review by the UK medications. The regulator discovered that at the end of March, people had suffered rare blood clots after vaccination, 19 of whom had died.

The regulator said that this was not a test that the Jab would have caused the clots.

But he said that the link was becoming firmer.

  • How do you weigh the risks of the AstraZeneca vaccine?

    The review by medicines and the Health Products Regulatory Agency (MHRA) found:

  • The 79 cases and 19 deaths occurred after 20 million doses, were administered , giving a risk of about four in a million developing a blood clot, and one in a million dying
  • almost two-thirds of rare clots were observed in women < Li> The people who died were aged between 18 and 79 years old. , with three of them under 30 years of age
  • , all registered cases occurred after the first dose, although the minor number of second dose meant that it was not possible to draw conclusions of this

    Meanwhile, the EU drug regulator said that unusual blood clots should be included as a possible very rare side effect of Astrazeneca Jab, but that the benefits exceeded the risks. Some European countries have restricted the use of the vaccine.

    The World Health Organization, said that the link between the vaccine and blood clots was "plausible", but not confirmed, and it was confirmed that coagulation incidents were "very rare" between almost 200 million people who have received the WORLDWIDE JAB.

    Analysis: Should we worry about one risk one in a million?

    No treatment or vaccine is free of risks. The key question is if it does it rather than the damage.

    The update of Wednesday once again shows that the vaccine against the AstraZeneca does, even if it assumes that it is causing these clots, which has not yet been tested.

    The risk of dying of one of them after vaccination is incredibly small, about one in a million.

    On the contrary, Covid kills one in eight people who are infected over 75, and one in 1,000 infected in their 40 years among those who develop symptoms.

    It is cut less clear for children under 30, who are less likely to die from Covid, although the Astrazaneca vaccine still has more benefit than risk.

    However, other vaccines can be an even better bet.

    The risk may seem worried, but it is actually very low, and we usually do not think about things only in terms of risk.

    For example, travel 250 miles in a car also carries with it a unique probability in a million to die in an accident. How many do you think about that when they get behind the wheel?

    Ministry of Health Matt Hancock said that the UK review confirmed that Jab Oxford-AstraZeneca is "safe, effective and benefits far outweigh the risks for the vast majority of adults."

    Prime Minister Boris Johnson said that the Astrazaneca vaccine "had already saved thousands of lives" and the new Council should ensure that people of all ages "continue to have confidence in vaccines."

    The Labor Leader, Sir Keir Starmer, also urged people to "trust our doctors and scientists" and said he was looking forward to receiving his second dose of Astrazeneca.

    AstraZeneca said both MHRA and EMA reviews reaffirmed that benefits. of the vaccine "continues to grow far from risks."

    Image of How to find a teaching job in Universities in China
    Rate and Comment
    Image of Across China: Coffee beans brew close Sino-African ties
    Across China: Coffee beans brew close Sino-African ties

    by Xinhua Writers Ye Ting, Zhang Dan, Zhang Yujie Changsha, September 28 (Xinhua) - After Working in the coffee industry for more than 22 years, Ji

    Read more →

  • Login



    Already have an account? Login here

    contact us


    Add Job Alert